Articles by Daniel Marsh
PDS Biotech Soars 36% on $22.55M Financing: Dilution Concerns Loom
PDS Biotechnology (PDSB) surged 36% after announcing a $22.55 million PIPE led by Nant Capital, but the deal involves significant dilution. Here's the breakdown.
ATAI Stock Holds at $7.28 as Lilly Deal Nears Close; CVR Value Priced at 53 Cents
ATAI shares closed at $7.28 after shareholders approved Eli Lilly's takeover. The market values the contingent value right at 53 cents, a fraction of its $2.50 maximum.
Howmet Plunges 11% as GE's $11.75B CPP Buy Reshapes Supplier Dynamics
Howmet shares dropped 10.7% after GE's $11.75B CPP deal. The acquisition could alter supplier bargaining power, but Howmet's technology and financials stay robust.
NuScale Power Soars 15% on No News; Dilution Overhang Looms
NuScale Power shares rallied 15% to $11.18 without any new orders or announcements, but the stock now trades just above its recent ATM offering price, highlighting dilution and cash burn concerns.
Cognizant Drops 3.8%: Is the AI-Driven Valuation a Bargain or a Trap?
Cognizant shares dropped 3.8% to $59.92, trading at 10.4 times earnings. The low valuation sparks debate: is it a bargain or a warning about AI's impact?
UK Mortgage Costs Climb to 5.13%: What It Signals for Bank Stocks
UK fixed mortgage rates rose to 5.13% (two-year) as swap rates climbed, pressuring bank margins. Lenders like Lloyds (LYG) face a volume-pricing trade-off.
VIX Climbs to 15.72 as Futures Curve Signals Caution Ahead of CPI
The VIX rose 2.75% to 15.72, but futures suggest higher near-term volatility ahead of key inflation reports and a Fed meeting.
Wix Shares Slide 17.7% in Four Days as AI Strategy Faces Market Scrutiny
Wix shares dropped 17.7% in four sessions, closing at $72.72. The market is reassessing AI profitability, buyback leverage, and cash flow guidance.
Six Flags' ArieForce One Deal: A Test of Capital Discipline
Six Flags' acquisition of ArieForce One boosts stock 1.5%, but missing financial details leave investors questioning capital discipline.


